Do you want to read an article? Please log in or register.
Oncological impact of adjuvant chemotherapy after rectal cancer excision in the era of FOLFIRINOX-based TNT: A pooled post-hoc analysis of GRECCAR4-PRODIGE23
Gastrointestinal Cancer
Related content
RECOMMENDED
Breast Cancer
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial
★ 1
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
Lancet Oncol
Yuan J, Bi XW, Hua X, Huang H, Cai L, Zhao L, Chen QJ, Chen XX, Wang XL, Lin Y, Zhang AQ, Zhong YY, Xu F, Huang JJ, An X, Shi YX, Wang X, Wang SS, Xue C, Yuan ZY
doi: 10.1016/S1470-2045(25)00545-5
Lung, Respiratory and Thoracic Cancer
Adjuvant chemotherapy intensity and prognosis in completely resected high-grade neuroendocrine lung carcinoma: a post hoc analysis of JCOG1205/1206
Lung Cancer
Isaka T, Kenmotsu H, Wakabayashi M, Yoshioka H, Shimada Y, Tsutani Y, Nakagawa K, Yotsukura M, Mitome N, Uozumi T, Daga H, Tanaka H, Kasai T, Niho S, Tsuboi M, Fukuda H, Aokage K, Okamoto I, Watanabe SI, Japan Clinical Oncology Group JCOG
doi: 10.1016/j.lungcan.2026.109520
Gastrointestinal Cancer
Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis
J Natl Cancer Inst
Lopez-Lopez V, Hasse T, Houben P, Frey MC, Rangelova E, Genova L, Malleo G, Lionetto G, Lee SH, Abdurakhmonov S, Patel SH, Wilson GC, Ahmad SA, Schmocker RK, Lüthy M, Fritsch R, Palm RF, Hoffe SE, He J, Gordon-Weeks A, Lakha A, Pu N, Liu L, Owuor S, Sánchez-Velazquez P, Ielpo B, Beltrán P, Pérez-Benito MJ, Alonso IJ, Nutu A, Sobirov J, Zafra GM, Robles-Campos R, Pawlik TM, Pascher A, Yoo C, Oberholzer J, Eshmuminov D
doi: 10.1093/jnci/djag235
Lung, Respiratory and Thoracic Cancer
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial
Lancet Oncol
Brunetti L, Santo V, Pinato DJ, Citarella F, Orlando S, Acker F, Colella V, Ricciuti B, Naidoo J, Nassar A, Wakelee HA, Takada K, Naqash AR, Garassino MC, Greco C, Ramella S, Pantano F, Tonini G, Vincenzi B, Arlunno B, Remon J, Parisi C, Planchard D, Besse B, Desilets A, Routy B, Elkrief A, Barlesi F, Derosa L, Cortellini A
doi: 10.1016/S1470-2045(26)00191-9
Gastrointestinal Cancer
Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer: A Post Hoc Analysis of the TOPAZ-1 Randomized Clinical Trial
JAMA Oncol
Oh DY, He AR, Qin S, Chen LT, Okusaka T, Griffin R, Wang J, Xynos I, Vogel A, Valle JW
doi: 10.1001/jamaoncol.2026.2204
Breast Cancer
Adjuvant chemotherapy in stage I triple-negative breast cancer: A systematic review and meta-analysis of survival outcomes
Cancer Treat Rev
Jacobs F, Polymeropoulos A, Monte M, Ligorio F, Provenzano L, Armani G, Fotia G, Mazzoli G, Coppola G, Bottelli A, Iacobucci A, Bianchessi V, Abate A, Bianchi GV, Capri G, Ferraris C, Martelli G, Folli S, Vingiani A, Pruneri G, Miceli R, Vernieri C
doi: 10.1016/j.ctrv.2026.103156
CHICAGO 2026
Genitourinary Cancer
ENGOT-EN6-NSGO/GOG-3031/RUBY: Post hoc analyses show sustained survival benefit with dostarlimab plus chemotherapy in dMMR/MSI-H endometrial cancer
Gastrointestinal Cancer
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial
JAMA Oncol
Zhang GQ, Meyerhardt JA, Shi Q, Twombly T, Pederson L, Ma C, Väyrynen JP, Zhao M, Takashima Y, Shergill A, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Tan B, O'Reilly EM, Giannakis M, Ogino S, Jurdi A, Sharma S, Aleshin A, Shields AF, Nowak JA
doi: 10.1001/jamaoncol.2025.5144
Gastrointestinal Cancer
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers
J Clin Oncol
Noiret B, Perez RO, Conroy T, Brown CJ, Schrag D, Fernandez L, Lefevre JH, Benoist S, Rouanet P, Garcia-Aguilar J, Denost Q
doi: 10.1200/JCO-25-01861